{"id":"https://genegraph.clinicalgenome.org/r/a48a7957-cd5d-4dc8-aa52-93bb847bcb17v1.1","type":"EvidenceStrengthAssertion","dc:description":"ARF1 was first reported in relation to autosomal dominant periventricular nodular heterotopia in 2016 (Ge et al., PMID: 28868155). Nine variants (missense, frameshift, nonsense) that have been reported in over 10 probands in 4 publications (PMIDs: 28868155, 34353862, 36345169, 37185208) are included in this curation. Not all probands have periventricular nodular heterotopia; the range of the phenotype includes variable facial anomalies, developmental delay, intellectual disability, seizures, and motor abnormalities. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity appears to be haploinsufficiency. This gene-disease relationship is also supported by experimental evidence (mouse model, functional alteration evidence, rescue evidence; PMIDs: 25305484, 37118341, 38014604). Mutant mice show embryonic lethality. Functional alteration indicates abnormal mitotic spindle assembly, demyelination, and neuronal degradation in the mutants. Abnormal mitotic spindle assembly is partially reduced in mutants that receive ARF1 mRNA supplementation. In summary, there is definitive evidence supporting the relationship between ARF1 and autosomal dominant periventricular nodular heterotopia. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Brain Malformations GCEP on the meeting date 6/25/2024 (SOP Version 10).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/a48a7957-cd5d-4dc8-aa52-93bb847bcb17","GCISnapshot":"https://genegraph.clinicalgenome.org/r/5b42038d-6fb1-40be-96c3-1e97eacd9092","calculatedEvidenceStrength":"Definitive","changes":{"id":"cg:summaryChange"},"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/5b42038d-6fb1-40be-96c3-1e97eacd9092_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10020","date":"2024-06-28T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/5b42038d-6fb1-40be-96c3-1e97eacd9092_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10020","date":"2024-07-09T14:23:46.992Z","role":"Publisher"}],"curationReasonDescription":"Total score for genetic evidence should actually be, as the interface would not let me the second case (scored at 1 pt.) for one of the missense variants. ","curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5b42038d-6fb1-40be-96c3-1e97eacd9092_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fde19fde-0e9c-4a0c-a2c9-bf1b83fb5aa0","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fde19fde-0e9c-4a0c-a2c9-bf1b83fb5aa0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28868155","allele":{"id":"https://genegraph.clinicalgenome.org/r/da430cff-8849-4c0b-86e5-727f5bd7b6fa","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001658.4(ARF1):c.379A>G (p.Lys127Glu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA345079416"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/fde19fde-0e9c-4a0c-a2c9-bf1b83fb5aa0_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"In 293T cell analysis, variant nucleotide activation of ARF1 in the mutant was substantially reduced in comparison to the wild type","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/99b19eac-29c3-4f63-8dbc-453bba8f9c6c","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/99b19eac-29c3-4f63-8dbc-453bba8f9c6c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37185208","allele":{"id":"https://genegraph.clinicalgenome.org/r/da430cff-8849-4c0b-86e5-727f5bd7b6fa"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/99b19eac-29c3-4f63-8dbc-453bba8f9c6c_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"In 293T cells, the variant nucleotide activation of ARF1 in the mutant was substantially reduced in comparison to the wild type.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/8aa5ddac-bb98-43b9-8a5f-00f07bee1b95","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8aa5ddac-bb98-43b9-8a5f-00f07bee1b95_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37185208","allele":{"id":"https://genegraph.clinicalgenome.org/r/5ec0b1a8-7014-418d-b32f-5856c6eb0443","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001658.4(ARF1):c.143C>T (p.Thr48Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA345077938"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/8aa5ddac-bb98-43b9-8a5f-00f07bee1b95_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Variant nucleotide activation of ARF1 in the mutant was substantially reduced in comparison to the wild type.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/7a4b9e93-f3eb-4c5d-8414-9de4d8c87007","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7a4b9e93-f3eb-4c5d-8414-9de4d8c87007_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37185208","allele":{"id":"https://genegraph.clinicalgenome.org/r/aca3952f-4615-4d3a-9a5b-82c523bc1d72","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001658.4(ARF1):c.296G>A (p.Arg99His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA345078903"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/7a4b9e93-f3eb-4c5d-8414-9de4d8c87007_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Variant exhibited typical expression and localization to Golgi apparatus, but, in HeLa cells, led to swelling of Golgi, increasing amount of coat proteins, and changed shape of recycling endosomes.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/2b305dd1-8647-403d-86d0-84848976b9d6","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2b305dd1-8647-403d-86d0-84848976b9d6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37185208","allele":{"id":"https://genegraph.clinicalgenome.org/r/9a104cb8-a678-4c06-917d-144311d74087","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001658.4(ARF1):c.153C>A (p.Phe51Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA345077970"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/2b305dd1-8647-403d-86d0-84848976b9d6_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"In 293T cells, variant nucleotide activation of ARF1 in the mutant was substantially reduced in comparison to the wild type ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/761dfd0a-366a-4a93-b2c5-c0ebd1740989","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/761dfd0a-366a-4a93-b2c5-c0ebd1740989_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37185208","allele":{"id":"https://genegraph.clinicalgenome.org/r/38fbe4d8-1f9c-41d8-95eb-c6f350a5d6e1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001658.4(ARF1):c.151T>C (p.Phe51Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA345077966"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/761dfd0a-366a-4a93-b2c5-c0ebd1740989_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"In 293T cells, variant nucleotide activation of ARF1 in the mutant was substantially reduced in comparison to the wild type.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/5a2675dc-1d86-4aff-93bc-583fa2d59d6e","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5a2675dc-1d86-4aff-93bc-583fa2d59d6e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37185208","allele":{"id":"https://genegraph.clinicalgenome.org/r/d414872e-cfdf-4eeb-8f53-17943d644eae","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001658.4(ARF1):c.55C>T (p.Arg19Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA345077745"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/1d2080e7-7150-4e91-9f6c-17a77436c609","type":"EvidenceLine","dc:description":"This variant is p.Trp78Ter. ","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1d2080e7-7150-4e91-9f6c-17a77436c609_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34353862","allele":{"id":"https://genegraph.clinicalgenome.org/r/de0621c0-6599-41be-b8b3-bf71bed33c29","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001658.4(ARF1):c.233G>A (p.Trp78del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA345078447"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/dea83bd6-bfb3-449c-844f-7a05d4b9ecf1","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dea83bd6-bfb3-449c-844f-7a05d4b9ecf1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28868155","allele":{"id":"https://genegraph.clinicalgenome.org/r/6fa1d57c-af30-481c-a72c-f4baa7f45e40","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001658.4(ARF1):c.103T>C (p.Tyr35His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA38716145"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/dea83bd6-bfb3-449c-844f-7a05d4b9ecf1_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Variant reduced nucleotide activation in 293T cells compared to wild type.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/51ab77d2-ba4a-4577-b0ba-3140fecec6c6","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/51ab77d2-ba4a-4577-b0ba-3140fecec6c6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28868155","allele":{"id":"https://genegraph.clinicalgenome.org/r/aca3952f-4615-4d3a-9a5b-82c523bc1d72"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/51ab77d2-ba4a-4577-b0ba-3140fecec6c6_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Variant exhibited typical expression and localization to Golgi apparatus, but, in HeLa cell analysis, led to swelling of Golgi, increasing amount of coat proteins, and changed shape of recycling endosomes (Ishida et al., (PMID: 36345169)). ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/1a40927b-d48d-40be-b422-44f9f90c4eca","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1a40927b-d48d-40be-b422-44f9f90c4eca_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37185208","allele":{"id":"https://genegraph.clinicalgenome.org/r/d414872e-cfdf-4eeb-8f53-17943d644eae"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/4404a593-a9b2-4572-877c-8bfbb3f65d70","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4404a593-a9b2-4572-877c-8bfbb3f65d70_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36345169","allele":{"id":"https://genegraph.clinicalgenome.org/r/aca3952f-4615-4d3a-9a5b-82c523bc1d72"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/4404a593-a9b2-4572-877c-8bfbb3f65d70_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Variant exhibited typical expression and localization to Golgi apparatus, but, in HeLa cells, led to swelling of Golgi, increasing amount of coat proteins, and changed shape of recycling endosomes.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/03a49cbc-0eb1-4ceb-94ec-9f84dc8c4279","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/03a49cbc-0eb1-4ceb-94ec-9f84dc8c4279_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37185208","allele":{"id":"https://genegraph.clinicalgenome.org/r/7cfb565b-2db3-4fe5-b48d-9eb1ca72d90d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001658.4(ARF1):c.214del (p.Asp72ThrfsTer17)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573051504"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/5b42038d-6fb1-40be-96c3-1e97eacd9092_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5b42038d-6fb1-40be-96c3-1e97eacd9092_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/324c8c6d-323a-4789-a1d0-e2714fe6ffa9","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4c6da4ef-af25-4f3f-8dad-d362792a2970","type":"FunctionalAlteration","dc:description":"There was a substantial reduction in ARF1 protein concentrations in siRNA-injection oocytes (ARF1-knockdown) in comparison to the control. The knockdown of ARF1 significantly increased the proportions of abnormal protein kinases Aurora A and Plk1.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/38014604","rdfs:label":"siRNA injection, functional alteration"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/93b51eab-1ed7-4007-a465-d2d966a82a83","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3eba3d04-a244-456d-acd0-a6001e9f296e","type":"FunctionalAlteration","dc:description":" The ARF1-/- homozygous neuronal-specific knockouts (mice) had significant demyelination and neuronal degeneration compared to the heterozygous (+/-) mice. Neuronal number was markedly reduced in the homozygous knockout, as well as the levels of PSD95+SYP+. Both PSD95 & SYP are key for synaptic vesicle endocytosis/localization.  \n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37118341","rdfs:label":"Functional alteration, mouse analysis"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/5b42038d-6fb1-40be-96c3-1e97eacd9092_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7e315a44-edc1-481c-b1c1-6137d4d40677","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/89f019c4-111b-414d-9146-b5913403679c","type":"Finding","dc:description":"mRNA supplementation of ARF1 was able to partly recover function (normal mitotic spindle assembly)","dc:source":"https://pubmed.ncbi.nlm.nih.gov/38014604","rdfs:label":"Cell culture model rescue ","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityCellCultureRescueCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/336fe4ac-8b07-4eae-9aef-429de4bca648","type":"EvidenceLine","dc:description":"This is an autosomal dominant condition, and the heterozygotes did not appear abnormal. Also, there was no specific brain phenotype noted in the mice. Thus, the score was downgraded. ","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/645bc78c-daea-4768-9a82-4af4006a1619","type":"Finding","dc:description":"The mice were not shown to have the specific phenotype of the disease seen in humans, which includes periventricular nodular heteropia, intellectual disability, and structural brain anomalies. However, the embryonic lethality shown in the homozygous mutants shows that this gene is important in development, including brain development. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25305484","rdfs:label":"Mouse model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2.5}],"evidenceStrength":"Definitive","sequence":8683,"specifiedBy":"GeneValidityCriteria10","strengthScore":14.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/Nfm7mfj6yzU","type":"GeneValidityProposition","disease":"obo:MONDO_0020341","gene":"hgnc:652","modeOfInheritance":"obo:HP_0000006"},"version":"1.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_5b42038d-6fb1-40be-96c3-1e97eacd9092-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}